Since medical cannabis was legalised in the UK in November 2018, public understanding of this treatment option has significantly increased, following high profile campaigns such as access to cannabis for children with epilepsy and new treatments for patients with Multiple Sclerosis.
According to research carried out by the Centre for Medicinal Cannabis in 2019, 1.4m people in the UK have used cannabis for medical reasons and over 11% of UK adults (6 million people) have tried a CBD product. It’s fair to say that more people than ever are exploring the benefits of this treatment.
What does this mean for the UK’s clinicians?
How should you be talking to your patients about medical cannabis? In this new guide for UK clinicians, our expert committee and medical cannabis patients advise.